Company News
Indoco's AnaCipher Receives ANVISA Brazil Facility Approval
Indoco's CRO subsidiary AnaCipher received approval from Brazil's ANVISA for its clinical and bioanalytical facilities following a March-April 2026 inspection.
The approval authorizes AnaCipher to con
